Emergent BioSolutions Inc (EBS)

8.30 +0.15 (+1.84%) USD  |  NYSE  |  Dec 24, 16:00
More

Emergent BioSolutions Adjustments for Foreign Currency Translation (Quarterly)

Adjustments for Foreign Currency Translation (Quarterly) Chart

View Adjustments for Foreign Currency Translation (Quarterly) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Adjustments for Foreign Currency Translation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Adjustments for Foreign Currency Translation Definition

View Adjustments for Foreign Currency Translation Definition
Start Trial

Adjustments for Foreign Currency Translation is a line item under shareholder's equity on the company's balance sheet. These are included to compensate for the difference between the foreign currency and the domestic currency.

Read full definition.

Adjustments for Foreign Currency Translation (Quarterly) Range, Past 5 Years

View Adjustments for Foreign Currency Translation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Adjustments for Foreign Currency Translation (Quarterly) Benchmarks

View Adjustments for Foreign Currency Translation (Quarterly) Benchmarks
Start Trial
Abbott Laboratories --
Tonix Pharmaceuticals Holding Corp --
Chimerix Inc --
Geron Corp --
MAIA Biotechnology Inc --